Adicet Bio, Inc. Profile Avatar - Palmy Investing

Adicet Bio, Inc.

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies…

Biotechnology
US, Boston [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of ACET's Analysis
CIK: 1720580 CUSIP: 007002108 LEI: - UEI: -
Secondary Listings
ACET has no secondary listings inside our databases.